Clear Street’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

Clear Street’s Portfolio EBACU Stock Details EBACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,598	Closed	-$77K	–	1465
2022 Q4	$77K	Buy	7,598 +3,078	+68%	+$30.8K	﹤0.01%	199
2022 Q3	$45K	Sell	4,520 -6,693	-60%	-$66.2K	﹤0.01%	330
2022 Q2	$109K	Buy	+11,213	New	+$110K	﹤0.01%	139

Clear Street's EBACU Position: Q1 2023 in Review

Clear Street sold out of European Biotech Acquisition Corp. Units (EBACU) in Q1 2023, closing a stake of 7,598 shares — an estimated $77K sold.

Clear Street first reported a position in EBACU in Q2 2022 and held it in 3 quarters. The position peaked at $109K in Q2 2022. 0 funds tracked by Wall St. Rank hold EBACU as of Q1 2023.

Clear Street reported no remaining European Biotech Acquisition Corp. Units position as of Q1 2023 after selling out during the quarter.
Clear Street sold 7,598 European Biotech Acquisition Corp. Units shares in Q1 2023, an estimated $77K.
Clear Street first reported a position in European Biotech Acquisition Corp. Units in Q2 2022 and held it in 3 quarters.
Clear Street's European Biotech Acquisition Corp. Units position peaked at $109K in Q2 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q1 2023.

Based on Clear Street's 13F filing for Q1 2023, filed 12 May 2023.